These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan. Sakamaki Y, Sasamura H, Ikeda S, Ikegami N, Saruta T. Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153 [Abstract] [Full Text] [Related]
23. The economic burden of chronic cardiovascular disease for major insurers. Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D. Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951 [Abstract] [Full Text] [Related]
24. High blood pressure in Latin America: a call to action. Rubinstein A, Alcocer L, Chagas A. Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):259-85. PubMed ID: 19561117 [Abstract] [Full Text] [Related]
27. [Economic assessment of the epidemiological profile change: information for health care reforms]. Arredondo A. Rev Med Chil; 1997 Feb; 125(2):244-52. PubMed ID: 9430948 [Abstract] [Full Text] [Related]
31. Migration, mental health and costs consequences in Romania. Miclutia I, Junjan V, Popescu CA, Tigan S. J Ment Health Policy Econ; 2007 Mar; 10(1):43-50. PubMed ID: 17417046 [Abstract] [Full Text] [Related]
33. Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences. Adhikari SR, Maskay NM, Sharma BP. Health Policy Plan; 2009 Mar; 24(2):129-39. PubMed ID: 19181674 [Abstract] [Full Text] [Related]
34. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis. Huse DM, Song X, Ozminkowski RJ, Maguire J, Williams SA, Borok GM, McDonough K. Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315 [Abstract] [Full Text] [Related]